Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Humoral Rejection in Kidney Transplantation”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT01106027
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mayo Clinic 2
Not applicableEnded earlyNCT02095821
What this trial is testing

Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

Who this might be right for
Clotting Disorder Due to Plasma Exchange TherapyHumoral Rejection After Kidney Transplantation
Hannover Medical School 2
Not applicableNot Yet RecruitingNCT05890430
What this trial is testing

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

Who this might be right for
Kidney TransplantationKidney Allograft BiopsyHumoral Rejection+1 more
University Hospital, Strasbourg, France 570
Testing effectiveness (Phase 2)Ended earlyNCT00568477
What this trial is testing

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

Who this might be right for
GraftingRenal TransplantationTransplantation, Kidney+1 more
Technical University of Munich 200
Not applicableStudy completedNCT03016455
What this trial is testing

B Cell Lymphocyte in Humoral Rejection and Alloimmunisation

Who this might be right for
Renal Transplant
University Hospital, Brest 116
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Not applicableNot Yet RecruitingNCT04164576
What this trial is testing

Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients

Who this might be right for
Renal-urinary ImpairmentGraft RejectionInfection Episodes
University Hospital, Strasbourg, France 120
Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02738918
What this trial is testing

Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.

Who this might be right for
Renal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor
Assistance Publique - Hôpitaux de Paris 51
Not applicableStudy completedNCT04851145
What this trial is testing

Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.

Who this might be right for
Kidney TransplantationGraft RejectionHumoral Immunity+1 more
University Hospital, Bordeaux 141
Large-scale testing (Phase 3)Study completedNCT01350882
What this trial is testing

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

Who this might be right for
Humoral Rejection in Kidney Transplantation
University Hospital, Tours 40